Related Experiment Video
Updated: May 22, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Implication of TGF-β as a survival factor during tumour development
1Laboratory of Biochemistry, Showa Pharmaceutical University, Machida, Tokyo, Japan. sitoh@ac.shoyaku.ac.jp
Journal of Biochemistry
|April 25, 2012
Summary
Transforming growth factor-beta (TGF-β) acts as a survival factor in metastatic breast cancer by suppressing apoptosis. Inhibiting activin receptor-like kinase 5 (ALK5) may offer a therapeutic strategy for these cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Transforming growth factor-beta (TGF-β) exhibits dual roles in tumor progression, inhibiting early stages and promoting late stages.
- The precise mechanisms by which TGF-β signaling influences tumor cell survival remain incompletely understood.
- Previous research highlighted TGF-β's context-dependent effects on tumorigenesis.
Purpose of the Study:
- To elucidate the role of autocrine TGF-β signaling as a survival mechanism in highly metastatic breast cancer cells.
- To investigate the involvement of BH3-only protein Bim and forkhead box C1 (Foxc1) in TGF-β-mediated cell survival.
- To explore the potential therapeutic implications of targeting TGF-β signaling in metastatic breast cancer.
Main Methods:
- Analysis of TGF-β1 and TGF-β3 expression in metastatic breast cancer cells.
- Assessment of Bim protein expression levels following TGF-β stimulation.
- Investigation of the regulatory relationship between TGF-β, Foxc1, and Bim expression.
Main Results:
- Highly metastatic breast cancer cells abundantly express TGF-β1 and TGF-β3.
- Autocrine TGF-β signaling suppresses the expression of the pro-apoptotic protein Bim.
- TGF-β stimulation leads to decreased expression of Foxc1, which is implicated in Bim regulation.
- TGF-β signaling promotes breast cancer cell survival by inhibiting apoptotic pathways.
Conclusions:
- Autocrine TGF-β signaling confers a survival advantage to certain metastatic breast cancer cells by downregulating Bim.
- The TGF-β-Foxc1-Bim axis represents a novel mechanism for promoting cancer cell survival.
- Inhibitors of activin receptor-like kinase 5 (ALK5) kinase may represent a promising therapeutic approach for metastatic breast cancers dependent on this pathway.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...